Public signalCompany raiseAuto-indexed · Unverified
Vizgen, Inc. raised $107.6M
Vizgen, Inc.· CAMBRIDGE, US· Biotechnology· Filed Oct 22, 2024
Vizgen, Inc. reported raising capital. Based in CAMBRIDGE, MASSACHUSETTS, US. First sale reported 2024-10-08. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$107.6M
Confidence90%
Raised
$107.6M
Investors
61
Jurisdiction
DELAWARE
On the record
- Location
- CAMBRIDGE, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $107.6M
- Filing date
- Oct 22, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 61
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- Indefinite
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Andrea Jackson
Director
Waltham, US
Christian Uhrich
Director
Waltham, US
David Walt
Director
Walthalm, US
Keith Crandell
Director
Waltham, US
Matthew Posard
Director
Waltham, US
Robert Carson
Executive Officer
Waltham, US
Seth Benson
Executive Officer
Cambridge, US
Simona Levi
Executive Officer
Waltham, US
Terry Lo
Director
Cambridge, US
Sources & provenance
“Operating company sold 107,575,628 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Oct 22, 2024. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnologyOver $100MCompany Raise
Are you associated with Vizgen, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record